Ron Bentsur - CEO, Xtl Biopharmaceuticals Ltd

As of August 21, 2007


Ron Bentsur Net Worth

  • Net worth is estimated to be at least $17.31M
  • Owns at least 20,101 units of Xtl Biopharmaceuticals Ltd stock

Ron Bentsur Trading

  • Largest purchase of shares was 15,279 units , worth over $19.86K on August 21, 2007
  • In total has made about 2 transactions over a year
  • Usually trades in August, with the busiest year in 2006 and 2007
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Ron Bentsur Mailing Address

  • Mailing address is 750 Lexington Ave 20th Fl New York NY 10022 NY

Xtl Biopharmaceuticals Ltd Insider Trading

  • The most recent transaction was 40,050,370 units sold on December 3, 2008 by Joseph Edelman, Perceptive Advisors Llc and Perceptive Life Sciences Master Fund Ltd worth over $5.81M
  • In the last 2 years, insiders at Xtl Biopharmaceuticals Ltd sold an estimated value of $5.81M and bought an estimated value of $94.37M
  • The most active traders are Joseph Edelman,  Perceptive Advisors Llc,  and Perceptive Life Sciences Master Fund Ltd
  • Insider trading is most common in January, with the busiest year in 2008

XTL BIOPHARMACEUTICALS LTD Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1